Defective oligomerization of arylsulfatase A as a cause of its instability in lysosomes and metachromatic leukodystrophy

Bulow von R, Schmidt B, Dierks T, Schwabauer N, Schilling K, Weber E, Uson I, Figura von K (2002)
JOURNAL OF BIOLOGICAL CHEMISTRY 277(11): 9455-9461.

Zeitschriftenaufsatz | Veröffentlicht | Englisch
 
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
Bulow von, R; Schmidt, B; Dierks, ThomasUniBi; Schwabauer, N; Schilling, K; Weber, E; Uson, I; Figura von, K
Abstract / Bemerkung
In one of the most common mutations causing metachromatic leukodystrophy, the P426L-allele of arylsulfatase A (ASA), the deficiency of ASA results from its instability in lysosomes. Inhibition of lysosomal cysteine proteinases protects the P426L-ASA and restores the sulfatide catabolism in fibroblasts of the patients. P426L-ASA, but not wild type ASA, was cleaved by purified cathepsin L at threonine 421 yielding 54- and 9-kDa fragments. X-ray crystallography at 2.5-Angstrom resolution showed that cleavage is not due to a difference in the protein fold that would expose the peptide bond following threonine 421 to proteases. Octamerization, which depends on protonation of Glu-424, was impaired for P426L-ASA. The mutation lowers the pH for the octamer/ dimer equilibrium by 0.6 pH units from pH 5.8 to 5.2. A second oligomerization mutant (ASA-A464R) was generated that failed to octamerize even at pH 4.8. A464R-ASA was degraded in lysosomes to catalytically active 54-kDa intermediate. In cathepsin L-deficient fibroblasts, degradation of P426L-ASA and A464R-ASA to the 54-kDa fragment was reduced, while further degradation was blocked. This indicates that defective oligomerization of ASA allows degradation of ASA to a catalytically active 54-kDa intermediate by lysosomal cysteine proteinases, including cathepsin L. Further degradation of the 54-kDa intermediate critically depends on cathepsin L and is modified by the structure of the 9-kDa cleavage product.
Erscheinungsjahr
2002
Zeitschriftentitel
JOURNAL OF BIOLOGICAL CHEMISTRY
Band
277
Ausgabe
11
Seite(n)
9455-9461
ISSN
0021-9258
eISSN
1083-351X
Page URI
https://pub.uni-bielefeld.de/record/2350782

Zitieren

Bulow von R, Schmidt B, Dierks T, et al. Defective oligomerization of arylsulfatase A as a cause of its instability in lysosomes and metachromatic leukodystrophy. JOURNAL OF BIOLOGICAL CHEMISTRY. 2002;277(11):9455-9461.
Bulow von, R., Schmidt, B., Dierks, T., Schwabauer, N., Schilling, K., Weber, E., Uson, I., et al. (2002). Defective oligomerization of arylsulfatase A as a cause of its instability in lysosomes and metachromatic leukodystrophy. JOURNAL OF BIOLOGICAL CHEMISTRY, 277(11), 9455-9461. https://doi.org/10.1074/jbc.M111993200
Bulow von, R, Schmidt, B, Dierks, Thomas, Schwabauer, N, Schilling, K, Weber, E, Uson, I, and Figura von, K. 2002. “Defective oligomerization of arylsulfatase A as a cause of its instability in lysosomes and metachromatic leukodystrophy”. JOURNAL OF BIOLOGICAL CHEMISTRY 277 (11): 9455-9461.
Bulow von, R., Schmidt, B., Dierks, T., Schwabauer, N., Schilling, K., Weber, E., Uson, I., and Figura von, K. (2002). Defective oligomerization of arylsulfatase A as a cause of its instability in lysosomes and metachromatic leukodystrophy. JOURNAL OF BIOLOGICAL CHEMISTRY 277, 9455-9461.
Bulow von, R., et al., 2002. Defective oligomerization of arylsulfatase A as a cause of its instability in lysosomes and metachromatic leukodystrophy. JOURNAL OF BIOLOGICAL CHEMISTRY, 277(11), p 9455-9461.
R. Bulow von, et al., “Defective oligomerization of arylsulfatase A as a cause of its instability in lysosomes and metachromatic leukodystrophy”, JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 277, 2002, pp. 9455-9461.
Bulow von, R., Schmidt, B., Dierks, T., Schwabauer, N., Schilling, K., Weber, E., Uson, I., Figura von, K.: Defective oligomerization of arylsulfatase A as a cause of its instability in lysosomes and metachromatic leukodystrophy. JOURNAL OF BIOLOGICAL CHEMISTRY. 277, 9455-9461 (2002).
Bulow von, R, Schmidt, B, Dierks, Thomas, Schwabauer, N, Schilling, K, Weber, E, Uson, I, and Figura von, K. “Defective oligomerization of arylsulfatase A as a cause of its instability in lysosomes and metachromatic leukodystrophy”. JOURNAL OF BIOLOGICAL CHEMISTRY 277.11 (2002): 9455-9461.

16 Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

Recon3D enables a three-dimensional view of gene variation in human metabolism.
Brunk E, Sahoo S, Zielinski DC, Altunkaya A, Dräger A, Mih N, Gatto F, Nilsson A, Preciat Gonzalez GA, Aurich MK, Prlić A, Sastry A, Danielsdottir AD, Heinken A, Noronha A, Rose PW, Burley SK, Fleming RMT, Nielsen J, Thiele I, Palsson BO., Nat Biotechnol 36(3), 2018
PMID: 29457794
Impact of genetic variation on three dimensional structure and function of proteins.
Bhattacharya R, Rose PW, Burley SK, Prlić A., PLoS One 12(3), 2017
PMID: 28296894
Mutation Update of ARSA and PSAP Genes Causing Metachromatic Leukodystrophy.
Cesani M, Lorioli L, Grossi S, Amico G, Fumagalli F, Spiga I, Filocamo M, Biffi A., Hum Mutat 37(1), 2016
PMID: 26462614
Genotypic characterization of Brazilian patients with infantile and juvenile forms of metachromatic leukodystrophy.
Virgens MY, Siebert M, Bock H, Burin M, Giugliani R, Saraiva-Pereira ML., Gene 568(1), 2015
PMID: 25965562
Developing therapeutic approaches for metachromatic leukodystrophy.
Patil SA, Maegawa GH., Drug Des Devel Ther 7(), 2013
PMID: 23966770
Structural aspects of therapeutic enzymes to treat metabolic disorders.
Kang TS, Stevens RC., Hum Mutat 30(12), 2009
PMID: 19790257
Expression and purification of a human, soluble Arylsulfatase A for Metachromatic Leukodystrophy enzyme replacement therapy.
Martino S, Consiglio A, Cavalieri C, Tiribuzi R, Costanzi E, Severini GM, Emiliani C, Bordignon C, Orlacchio A., J Biotechnol 117(3), 2005
PMID: 15862354
Mutations c.459+1G>A and p.P426L in the ARSA gene: prevalence in metachromatic leukodystrophy patients from European countries.
Lugowska A, Amaral O, Berger J, Berna L, Bosshard NU, Chabas A, Fensom A, Gieselmann V, Gorovenko NG, Lissens W, Mansson JE, Marcao A, Michelakakis H, Bernheimer H, Ol'khovych NV, Regis S, Sinke R, Tylki-Szymanska A, Czartoryska B., Mol Genet Metab 86(3), 2005
PMID: 16140556
Defective endoplasmic reticulum-resident membrane protein CLN6 affects lysosomal degradation of endocytosed arylsulfatase A.
Heine C, Koch B, Storch S, Kohlschütter A, Palmer DN, Braulke T., J Biol Chem 279(21), 2004
PMID: 15010453
Novel mutations associated with metachromatic leukodystrophy: phenotype and expression studies in nine Czech and Slovak patients.
Berná L, Gieselmann V, Poupetová H, Hrebícek M, Elleder M, Ledvinová J., Am J Med Genet A 129A(3), 2004
PMID: 15326627
Biochemical characterization of two (C300F, P425T) arylsulfatase a missense mutations.
Marcão A, Simonis H, Schestag F, Sá Miranda MC, Gieselmann V., Am J Med Genet A 116A(3), 2003
PMID: 12503099
CD1-restricted antigen presentation: an oily matter.
Joyce S, Van Kaer L., Curr Opin Immunol 15(1), 2003
PMID: 12495740
Oligomerization capacity of two arylsulfatase A mutants: C300F and P425T.
Marcão A, Azevedo JE, Gieselmann V, Sá Miranda MC., Biochem Biophys Res Commun 306(1), 2003
PMID: 12788103
Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®
Quellen

PMID: 11777924
PubMed | Europe PMC

Suchen in

Google Scholar